# SymKardia, Inc.: Form D capital raise (Westlake, OH)

**Vendor Spend Propensity Score (CPA / Tax / Audit):** 70/100
**Estimated post-raise budget for this service type:** $80,000 (heuristic)

| Field | Value |
|---|---|
| Industry | Other Health Care (Healthcare & Life Sciences) |
| Operating company | Yes |
| Exemption | 506(b) |
| Amount sold | $4,000,000 |
| Total offering | $4,000,000 |
| Investors so far | 8 |
| First sale | 2025-01-10 |
| Filed | 2026-10-28 |
| Entity | Corporation, incorporated 2024 |

## Executives and related persons (as listed in the filing)
- Anthony Caparso: Executive Officer, Director
- Bruce KenKnight: Executive Officer
- Steven Girouard: Executive Officer
- Jonathan Piccini: Executive Officer
- Imad Libbus: Executive Officer
- Dwight Skinner: Executive Officer
- Robert Picarel: Director
- Arun Sridhar: Director
- Claudio Rumazza: Director
- Alain Garcinuno Collet: Director
- James Blouzard: Director

## Why this score
- Operating company: new capital typically funds hiring, facilities and vendors.
- Raised $4,000,000 so far.
- Healthcare & Life Sciences companies are a strong fit for CPA / Tax / Audit services.
- New filing (not an amendment): the raise is fresh.
- Incorporated in the last five years: likely still building out finance and insurance.

Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) (https://www.sec.gov/Archives/edgar/data/2141283/000214128326000002/). Last refreshed: 2026-11-04T15:17:01.911Z.
Informational only. SEC EDGAR Form D data is shown for business-development research; it is not investment advice and not an offer or solicitation to buy or sell any security. Not legal or financial advice.